key: cord-1004421-3cr0ml08 authors: Peixoto, Andressa Oliveira; Costa, Rafael Miranda; Uzun, Raísa; Fraga, Andrea de Melo Alexandre; Ribeiro, José Dirceu; Marson, Fernando Augusto Lima title: Applicability of lung ultrasound in COVID-19 diagnosis and evaluation of the disease progression: A systematic review date: 2021-03-22 journal: Pulmonology DOI: 10.1016/j.pulmoe.2021.02.004 sha: 8b1ab7684793a3e3aacca8e9c7df9c749c4c68d3 doc_id: 1004421 cord_uid: 3cr0ml08 INTRODUCTION: The COVID-19 pandemic originated in China and within about 4 months affected individuals all over the world. One of the limitations to the management of the COVID-19 is the diagnostic imaging to evaluate lung impairment and the patients’ clinical evolution, mainly, in more severe cases that require admission into the intensive care unit. Among image examinations, lung ultrasound (LU) might be a useful tool to employ in the treatment of such patients. METHODS: A survey was carried out on PubMed to locate studies using the descriptors: ((Lung ultrasound OR ultrasound OR lung ultrasonography OR lung US) AND (coronavirus disease-19 OR coronavirus disease OR corona virus OR COVID-19 OR COVID19 OR SARS-CoV-2)). The period covered by the search was December 2019 and October 2020 and the papers selected reported LU in COVID-19. RESULTS: Forty-three studies were selected to produce this systematic review. The main LU findings referred to the presence of focal, multifocal and/or confluent B lines and the presence of pleural irregularities. CONCLUSIONS: The use of LU in the evaluation of COVID-19 should be encouraged due to its intrinsic characteristics; a low cost, radiation free, practical method, with easy to sanitize equipment, which facilitates structural evaluation of lung damage caused by SARS-CoV-2. With the increase in the number of studies and the use of ultrasound scans, LU has been shown as a useful tool to evaluate progression, therapeutic response and follow-up of pulmonary disease in the COVID-19. Most of the studies under analysis had LU findings in common in the presence of SARS-CoV-2 infection. The most common finding was B lines, which had very distinct characteristics, 34 of which reported focal, diffuse and confluent B lines. (12, 15, 19, 20, 27, 29, 31, 33, 35, 36, (38) (39) (40) (41) 46, 71, 76, 77, 79, (81) (82) (83) (86) (87) (88) (89) (90) (91) (92) (93) (94) (95) (96) (97) Twenty-nine studies described consolidations of different types: small, large, linear, subpleural, multifocal and translobar, (12, 15, 19, 20, 27, 29, 31, 33, 35, 39, 41, 46, 71, 72, 76, 77, 79, 81, 82, 84, (87) (88) (89) (91) (92) (93) (94) 96, 98) associated with white lung (12, 35) and with air bronchograms. (19, 46) Nineteen studies described pleural irregularities, (12, 15, 19, 29, 31, 35, 38, 39, 41, 71, 79, 81, 86, 88, 89, 91, 93, 94, 98) and 19 reported pleural and subpleural line alterations, such as thickening or shred sign. (19, 20, 29, 33, 36, 38, 40, 46, 71, 76, 79, 81, 82, 84, 86, 89, 94) Ten studies referred to pleural effusion, (46, 71, 76, 79, 81, 84, 86, (91) (92) (93) 8 reported bilateral findings (15, 40, 72, 88, 91, 95, 96, 97) and 3 revealed preponderance of compromise in posterior areas. (88, 89, 98) Three studies associated appearance of A lines during recovery (41, 76, 89) and most of the papers reported the LU role in the serial evaluation of COVID-19 patients. (31, 33, 35, 39, 41, 76, 77, 79, 80, 81, 83, (84) (85) (86) 89) Other characteristics found were the presence of glass rockets (46) with or without the Birolleau variant (29) , also known as white lung. (70) Some studies reported radiological findings agreement between LU and HCRT. (15, 19, 27, 31, 33, 38, 39, 41, 46, 71, 72, 74, 77, 79, 87, 88, 92, 93, 96, 98) The main HCRT findings were ground glass opacities, "crazy-paving" pattern, consolidations, pulmonary infiltrates and pleural thickening as well as interlobular septal thickening. (19, 33, 38, 39, 41, 46, 71, 74, 77, 79, 82, 84, 87, 88, 90, (92) (93) (94) 96, 98) When comparing thorax HRCT features with those of LU in pneumonia resulting from COVID-19 the findings included (i) correlation of ground glass opacity with B lines (multifocal, discrete or confluent); (ii) presence of thickened pleura in HRCT with thickening of the pleural line in LU; (iii) pulmonary infiltrates as confluent B lines in LU; (iv) pulmonary consolidation in both techniques. (21) The finding "white lung" was also described as ground glass opacity in HRCT. (15, 19, 29, 31, 46, 71, 87, 96) The areas evaluated during LU presented varied results between studies; with the evaluation from 4 to 7 regions in each hemithorax depending on individual studies, (12, 15, 35, 36, 40, 41, (71) (72) (73) (74) (75) (76) (77) (78) (79) (80) (81) (83) (84) (85) (86) 88, 89, 91, 92, 96) totaling 8, 10, 12 and 14 assessment areas in these papers. Differences were found in relation to the type of transducer used, whose choice was related to the propaedeutic strategy of better evaluation of superficial regions or smaller thoraces such as in children, using the linear probe, or deeper regions and larger thoraces using the curved probe. (12, 15, 27, 36, 40, 41, 46, 71, 75, 76, (78) (79) (80) (81) 83, 85, (86) (87) (88) (89) 91, 96) . Only one study employed sectorial probe in the pulmonary evaluation, since the institution protocols of that study advocated the point-of-care cardiac evaluation. (84) Eighteen studies used LU scores. (12, 46, (71) (72) (73) (76) (77) (78) (79) (80) 83, 84, 85, 86, 88, 89, 91, 96) One study proposed a unified approach to standardize the use of LU in the clinical management of COVID-19 patients, (12) aspect, dense and widely distributed, with or without consolidations. In that study, 14 thoracic regions were evaluated, using a score from 0 to 42 points, in which higher score represented higher severity. Another study (46) applied an LU scoring method ranging from 0 to 36 points= consolidation/pulmonary tissue-like aspect or pleural effusion. (76) Other particularities and LU scores found in the studies listed above are detailed in Table 2 . The description of individual protection equipment use during LU examinations was carried out in 14 studies only. (12, 15, 19, 29, 31, 46, 73, 75, 76, 81, 83, 84, 86, 96) The common strategy to minimize the risk of transmission was making a LU machine available exclusively for COVID-19 exams combined with the use of protective covers for the probe and equipment. The LU examination had to be carried out, if possible, by 2 professionals, one of whom would be in direct contact with the patient and the other with the screen, the keyboard and the image acquisition and recording. (12, 31, 76) Another strategy employed to reduce the occupational risk when dealing with COVID-19 patients was the use of portable wireless transducers, making it easier to clean and handle the equipment. (12, 31, 36, 71, 78, 82, 86, 88, 89, 91 ,97) Figure 2 shows the main findings of the LU imaging described in the study. In the COVID-19 pandemic, it is necessary to seek tools that enable the evaluation of lung impairment by the disease, minimizing the involvement of multiple teams and the exposure of professionals in the health area to the SARS-CoV-2. The LU examination is an alternative in the respiratory system propaedeutic as it is a low-cost technique, highly portable and allows for repetition of exams, and can be performed at the J o u r n a l P r e -p r o o f patient's bedside. (12) (13) (14) 21, 23, 64) The LU may be used in several moments of the natural history of the SARS-CoV-2 colonization/infection as it can identify the pulmonary involvement and seriousness of the disease in patients with suspected or confirmed COVID-19. It can also help to reduce the use of X-ray and/or thorax HRCT. (17, 71, 75, 83, 94) In addition, LU is a low-cost tool that can be used in low-and average-income countries where HRCT might not be available, (12) however, specialization in the area is necessary to use this technique. The application of LU in the screening of COVID-19 symptomatic patients in the pre-hospital phase through pneumonia evaluation was described. (13, 72, 73, 91) Other studies also showed LU applicability in the home assistance of older people and helping prevent unnecessary hospital admission, since LU integrated to the clinic and physical examination resulted in more accurate diagnosis of COVID-19 and other respiratory disease in older populations. In addition, due to the overload of the health service caused by the pandemic, some countries implemented home care for the older population whenever possible. (73, 91) Additionally, LU can be used in suspected diagnosis and in the prognostic stratification of individuals with pneumonia through the extension of specific patterns and their evolution to the consolidation phase in emergency assistance; it makes possible the management of patients in intensive care in relation to the mechanical ventilation and ventilator weaning; it can also monitor the effect of the therapeutic measures, like alveolar recruitment maneuvers, implemented in seriously affected patients submitted to invasive mechanical ventilation with orotracheal intubation. (35, 80, 84) In clinical practice, when managing patients with acute hypoxemic respiratory failure due to COVID-19, deciding whether to proceed with the invasive mechanical ventilation and intubation might be a challenge; LU might be a helpful and accurate indicator of the ideal moment for intubation. (85) Lu et al. (2020) investigated the role of LU role in the evaluation of the severity of the pulmonary aeration loss in intubated patients due to pneumonia by SARS-CoV-2 and those that were not intubated. The study carried out LU evaluations at different moments in the hospital care, within the period of one week J o u r n a l P r e -p r o o f after the patients had been admitted in the intensive care unit. The author pointed out that the LU could evaluate dynamically the ventilation condition of the two groups of patients in the study during the treatment and enable the prediction of the disease decline. (85) Since a LU negative result, that is, without visible alterations, does not rule out a SARS-CoV-2 infection, LU cannot be considered a tool that substitutes the physical examination or the RT-PCR, but, it should be considered a complementary tool to be used in the screening of patients to detect mild symptoms and allow a fast and efficient decision. (91) However, it has become clear that in the COVID-19 pandemic, the characteristics suggesting alterations provoked by the disease appearing in a LU or in the HRCT, even in the event of a negative RT-PCR test, might be highly suggestive of a SARS-CoV-2 infection. (41) Antúnez The existing literature suggests using of HRCT for the COVID-19 diagnosis and as a triage tool to identify SARS-CoV-2 virus infection, because, although the nasopharynx swab presents a definite etiological diagnosis, this test also presents limitations, mainly due to its low sensitivity, (31, 51) which is lower than HRCT. (52) However, the HRCT is represents high cost, low availability, exposure to ionizing radiation that limits its use in some populations such as pregnant women, and the need for sedation in lower age groups. (16, 31, 75) Therefore, LU becomes an important tool for the triage and evaluation of patients presenting COVID-19 symptoms. (53, 75, 83) Pulmonary abnormalities might occur before clinical manifestations and some specialists recommend HRCT and LU to detect the presence of consolidations. (77) In an observational series, LU was shown to be a useful tool to evaluate and monitor lung impairment in pregnant women with COVID-19, playing an important role in the treatment decision. All the patients presented ultrasound characteristics indicating COVID-19 at admission and 3 patients obtained resolution of the ultrasound pulmonary alterations. (35) The use of LU in the follow-up and evolution evaluation has been described in several studies. ( uncomfortable and with respiratory failure were called non-refractory, while those presenting refractory respiratory failure with PaO2 (oxygen partial pressure)/FiO2 (oxygen inspired fraction) ≤100 or patients treated with extracorporeal membrane oxygenation, were classified as refractory group. The ground-glass opacity pattern and the consolidations were more frequent in the refractory group. In the follow-up, B lines were seen to transform into A lines, with reduction in and disappearance of consolidations. Therefore, it seems relevant to emphasize that the presence of more consolidation areas and interstitial syndrome might imply disease worsening. In addition, the study showed one more use for the LU to spot, with high specificity (~90%), patients that might need extracorporeal membrane oxygenation. When evaluating the child population, a study with 8 individuals from 0 to 17 years old documented improvement of radiological alterations throughout clinical evolution and resolution of the pulmonary disease caused by the COVID-19. One of the patients that presented a severe clinical situation was examined repeatedly with LU on alternate days and a reduction was noticed in the B lines pattern bilaterally one day before the clinical and radiographic improvement. In the same study, LU repeated before the hospital discharge showed improvement in the resolution of consolidations and interstitial patterns, consistent with the concomitant radiologic findings. (27) The reappearance of A lines was reported in the illness recovery phase. (41, 89) Gregorio-Hernandez et. al.,2020 described LU findings in newborns infected by SARS-CoV-2, carried out every 48 hours in the first week after diagnosis, and ascribed a score according to the severity of the pulmonary sound involvement and applied the score (from 0 to 3 points) to the 6 anatomical regions under evaluation. Newborns with an initial score from 3 to 4 points presented some degree of interstitial alveolar syndrome, and the newborn with the highest score evolved with the worst respiratory outcome. (12, 17, 46, 76, 78, 79) A step-by-step approach to safely performing LUS was described in several studies and recommended a systematically scanning of different zones in both hemithoraces proposing a point-awarding system to the LU findings and their correlation to the severity of the lung impairment. (17, 57, 78) Several studies reported scanning of three areas of the thorax: anterior, lateral and posterior segments and, next, superior and inferior. Thus, 6 regions were defined for each lung. (15,17,40, Therefore, LU showed higher sensitiveness than the thorax CT in the identification of alveolar and interstitial disorders, consolidations and pleural effusion. (92) Another study adopted a new protocol called CLUE (COVID-19 Lung Ultrasound in Emergency) involving an anatomical parameter, (57) a LU scoring system and oxygen requirement at the time of examination, in order to help the emergency clinician to make therapeutic decisions. The LU scoring system was reported as a valid tool for assessing regional and global lung aeration in Acute Respiratory Distress Syndrome in other studies, (58, 59) one that can be used in COVID-19 pneumonitis with several similar J o u r n a l P r e -p r o o f sonographic features. (21) LU scoring system points ranged from 0 to 3, in each zone, totaling 12 zones, with higher points allocated to severe lung changes. The severity was classified as mild (score 1 to 5), moderate (6 to 15) and severe (>15). Employing the CLUE protocol could help risk-stratify suspected COVID-19 patients and may decrease reliance on chest X-rays or HRCT chest during the initial clinical evaluation of suspected patients. Studies have evidenced LU accuracy in detecting acute illnesses and its non-inferiority in relation to thorax radiography in the differential diagnosis of pneumonias, pulmonary edema and pleural effusion; (15, 24) the use of this tool in chronic diseases such as cystic fibrosis was also evaluated. Despite the LU nonspecific findings that can occur in other illnesses including other viral pneumonias and a broad spectrum of non-infectious diseases (chronic obstructive pulmonary disease, neoplastic lymphangitis, pulmonary fibrosis and interstitial pulmonary disease), the homogeneous interstitial pattern seems to suggest the cardiogenic edema diagnosis, while a heterogeneous interstitial pattern, mainly in combination with subpleural consolidation and/or pleural thickening might suggest, in the pandemic clinical and epidemiological environment, pneumonia caused by the SARS-CoV-2 virus. (68) One study investigated ultrasound particularities that could help the distinction of bacterial pneumonia and the pneumonia caused J o u r n a l P r e -p r o o f by SARS-CoV-2. The differentiation by LU between viral and bacterial pneumonia is a challenge, however, in that assay the finding of B line artifacts, or partial or confluent B lines, small consolidations and pleural alterations was suggestive of the COVID-19. These findings are described in other interstitial pneumonic processes of viral etiology. (71) Isolated large lobar consolidation with or without pleural effusion and with dynamic air bronchograms indicates bacterial infection. (69) Some studies used the contrast-enhanced ultrasound to evaluate lungs regarding the presence of an underlying thrombosis process. Bedside contrast-enhanced ultrasound was indicated due to the presence of LU findings presented correlation with HRCT images; LU can be used in respiratory system propaedeutics as an alternative to the "stethoscope use". Special clothing and individual protection equipment are indispensable, since the manipulation of the stethoscope in pulmonary evaluation might create contamination risks for the health professionals and patients. COVID-19 normally induces a bilateral and diffuse interstitial pneumonia with asymmetric lesions and uneven distribution, mainly involving the lung periphery, which makes it particularly suitable for investigation using LU. (69) J o u r n a l P r e -p r o o f Studies have identified potential correlation between the LU patterns and the patients' clinical outcome. One of the assays in this study reported that each pulmonary area could be in a different stage of the disease, therefore, the global evaluation of the lungs is fundamental. (78) The POCUS allows for hemodynamic, cardiac and vascular evaluations (thromboembolic phenomena deep venous thrombosis). LU should be associated to the multisystem point-of-care exam, since the SARS-CoV-2 infection might be linked to myocarditis and a high incidence of thromboembolic events. Thus, multiorgan ultrasound evaluation in early treatment is useful to screening these complications at the bedside. More studies on LU application in the pediatric population are necessary; LU in COVID-19 score standardization; Improvement of reading/automatic identification of B line software, as reported in this study is still needed; (83) The advancement of the remote robotic ultrasound scanning technology assisted by the 5G network in real time by the use of big data, cloud storage and artificial intelligence must be improved. (82) Conclusions LU can be employed in different age groups to evaluate the seriousness and the response to treatment Case report 3 male newborns, case 1= 2 days old and GP = 38+3; case 2= 78 days old and GP = 39+3; and Case 3= 6 days old and GP = 39+6 (gestational period at the moment of the diagnosis). Case 1= mother with postpartum fever without respiratory symptoms. Cases 2 and 3= asymptomatic, but investigated after Case 1 diagnosis. Case report a 6-month-old male participant. Negative RT-PCR Detection of antiSARS-CoV-2 IgM and anti-SARS-CoV-2 IgG on day 21 of illness. 2-week history of nasal congestion and cough, irritability, tachypnoea (80 bpm), cyanosis (SpO2 81%), tachycardia (170 bpm), hypotension (59/32 mmHg), poor perfusion, weak peripheral pulses and hepatomegaly (3 cm). Short bowel syndrome with fever and cyanosis; cardiogenic shock secondary to severe pulmonary hypertension and right ventricular failure without pulmonary thromboembolism condition labelled as pediatric multisystem inflammatory syndrome. Prophylaxis with low molecular weight heparin; mechanical ventilation and prone position; inotropic support with milrinone and norepinephrine and broad-spectrum antibiotics (meropenem, vancomycin and fluconazole); Tocilizumab, azithromycin, hydroxychloroquine and methylprednisolone. Multifocal B lines; pleural and subpleural thickening; consolidation. Thorax X-ray with bilateral infiltrates. NS NS LU might be useful to manage COVID-19 suspected patients, ev allow the differentiation of the viral pneumonia cau Small and large consolidated areas, pleural irregularities, blank vertical areas and extensive blank lung with or without consolidation. None 0 to 3 points in 14 areas (three posterior, two lateral and two posterior in each hemithorax). Portable machines dedicated to exclusive use in COVID-19. Convex or Linear probes, according to the patient's body size. Experience of the service in the standardization of COVID-19 emphasis on the need for a shared data base. Irregular pleural line with small subpleural consolidations, blank lung areas, irregular and confluent vertical artifacts (B lines). Bilaterally present preserved areas and mixed with affected areas. Thorax X-ray with doubtful left peri-hylar hypodiafania and HRCT (ground glass pattern). 12 areas evaluated. Portable convex probe (3.5 MHz). Yes Evaluation using portable LU and two examiners B lines with variable aspect (focal, multifocal and confluent), subpleural consolidations, pleural thickening or irregularity and larger consolidations with occasional air bronchograms. HRTC with ground glass opacity. POCUS for cardiac scan. Handheld devices without probe description. Complete + ultrasound protective equipment. Antisepsis care and preventing contamination during Subpleural consolidations (2 patients). Confluent B lines (5 patients). Agreement with radiologic findings in 7 out of the 8 cases. One patient presented B line interstitial pattern, despite the normal thorax X-ray. Thorax X-ray with consolidation in two patients and ground glass opacities. Linear transducer from 7.5 to 13 MHz. NS LU showing high agreement with thorax X-ray examination; radiologic exams; able to stratify according to severity into mild severe; follow-up, exam repetition before discharg Glass rockets with or without Birolleau variant (white lung); confluent B lines and thick and irregular pleural lines; small subpleura consolidations (5 patients); large consolidation (1 patient). X-ray and tomography. NS Yes LU might be more sensitive than thorax X-ray in the diagnosis syndrome. When resources are limited, where thorax radiograph, RT-PCR are not promptly available or the response time is long COVID-19 diagnosis. Vertical artifacts, white lung areas, subpleural consolidations and pleural irregularities. X-ray (unspecified diffuse interstitial thickening), tomography (the findings of one case correlated to the LU findings) and resonance (signs of pneumonia). Thorax X-ray performed on the same day, did not suggest viral pneumonia. 14 regions (3 posterior, 2 lateral and 2 anterior) along the paravertebral, middle axillar and hemiclavicular lines. Convex wireless transducer (3.5 MHz). LU was shown to be an accurate imaging method to detect pleura pulmonary conditions, including pneumonia, with great accuracy, women. A lines. Focal and confluent B lines. Pleural line thickening and irregularities. Tomography: multilobar asymmetric lung lesions with peripheral distribution of ground glass opacities, consolidation, and crazy pavement pattern. 15 patients= coalescent B-lines (<3 mm); 5 patients= wide distance between B-lines (>7 mm) and the lung rocket sign; 3 patients= "white lung" sign; 6 patients= pulmonary consolidations including 2 with the presence of air bronchogram and 3 with shred signs; 3 patients= pleural thickening; 1 patient= pleural effusion; 1 patient= pneumothorax. CT showed patchy ground glass opacities, consolidations, reticular shadows, small amount of pleural effusion. Six regions for each hemithorax (anterior superior, anterior inferior, lateral superior, lateral inferior, posterior superior and posterior inferior) associated with a score method of 0-3 points in each area. Convex array transducer (2-5 MHz) and linear array transducer (5) (6) (7) (8) (9) (10) (11) (12) . Comparison between ultrasound score and tomography Bedside ultrasound exhibits relatively low sensitivity with respec vicinity of the pulmonary hilum, which influences the quantitativ lung lesions in patients with COVID-19. i. Thickened pleural line (12/12 patients); blurred or irregular (9/12 patients) and fragmented (6/12 patients); ii. Scattered B lines and comet tail signals (4/12 patients); partially diffuse (12/12 patients); completely CT with semi quantitative scoring method: ground-glass opacities, irregular pleural margin, septal or subpleural lines, honeycomb, subpleural cyst. 5 regions in each hemithorax. BLUE protocol and BLUE plus protocol. The scoring system (i) pleural line involvement, including thickened, blurred, irregular or discontinuous pleural line; (ii) lung The study pointed out some differences in the LU findings in CO pneumonia and community-acquired pneumonia The LU semiquantitative evaluation is viable to assess severity pneumonia, including in COVID-19. diffuse with white lung (10/12 patients) or waterfall sign (4/12 patients); iii. Pulmonary consolidations or subpleural focal lesions < 1cm (5/12 patients); iv. Pleural effusion (1/12 patient). Most patients were not submitted to CT. 12 areas (2 anterior, 2 lateral and 2 posterior on each side) Aeration score: 1 point= >2 B lines; 2 points= coalescent B lines; 3 points= consolidations. Strong association between consolidation and dyspn LU findings can precede the clinical condition. LU shows prognostic capability in SDRA before evidence of LU can define changes that affect the air/tissue relation on the Correlation between UP and CT and histopathological f LU was not carried out in the follow-up/evolution and hospitalized included. The most common findings of the study were not specified. None. 12 areas (2 anterior, 2 lateral and 2 posterior), score from 0 to 3, in which 1 point= presence of separated B lines occupying <50% of the pleural line; 2 points= presence of separated B lines occupying >50% of the pleural line; 3 points= lung thickening with a tissue aspect. Complete LU as mortality predictor = prognostic role. Greater accuracy when compared to the wrist oxime It can be used in nursing homes or households. Bias: small sample size and disregard of positive (such as medic negative factors (such as comorbidities and polypharm High diagnostic accuracy When compared to the X-ray in interstitial syndromes and alveolar consolidations. The most frequent LU findings are not specified. CT with ground glass opacity, consolidations and interlobular septal thickening. 12 areas, with the posterior ones in the posterior axillary line, rather than accessing via paravertebral. NS LU score predictive of pneumonia severity, as evaluated in the characteristics. LU associated to severity evaluated by the CT and clinical param possibility of substituting CT in the evaluation of the pulmonar POCUS for multiorgan evaluation: detection of deep venous thro right cardiac failure signals. Image with ionizing radiation in 1% -X-ray and CT (3 patients out of 296). 14 areas (10 seconds per area) The patients were considered negative for SARS-CoV-2 infection suspicion when the LU score was 0 or 1 (in the absence of symptoms); however, patients were considered positive for SARS-CoV-2 infection in the presence of score 1 and with symptoms, and scores 2 and 3. Complete LU used to screen SARS-CoV-2 infection concluding that the L more sensitive than the maternal symptoms in the infection Potential to be used as a triage tool and in the evaluation of disease advantage of being used freely during pregnancy reducing expos Most common findings in both groups were the B line patterns and shred sign. More ground glass opacity, consolidations and pleural effusion were observed in the refractory group. Cites CT as gold standard, but does not explain its use in the patients of the study. 10 areas (anterosuperior 2 nd ICS and anteroinferior 5 th ICS in the hemiclavicular line, laterosuperior 2 nd ICS and lateroinferior 5 th ICS in the mid-axillary line and posterior in the subscapular zone) Scores (from 0 to 40): 0= normal pattern with pleural sliding, parallel A lines and thin pleural line; 1 point= B line patterns; 2 points= ground glass signal with B lines occupying the whole screen; 3 points= fragmentation signal similar to small subpleural consolidations; 4 points= consolidation/ pulmonary hepatization signal or pleural effusion. Convex transducer. All images were reviewed and scored by 2 medical doctors with experience in LU applied to critical care. LU used in the followassessment: transformation of B lines into A lines; reduction and consolidations; more consolidations and more interstitial syndrom might mean disease worsening. LU can be used to evaluate aer patients. B line patterns and consolidations. CT: subpleural ground glass opacity with progressive extension and consolidations. 12 areas, score from 0 to 3 points, in which 0= normal; 1 point = well-defined B lines; 2 points= coalescent B lines and/or subpleural thickening ≤15 mm and subpleural consolidations); 3= consolidations (pleural thickening ≥15 mm), variation from 0 to 36 points. Higher score in deaths due to refractory hypoxemia and LU helpe of pneumonia associated to mechanical ventilatio Good agreement between CT and LU for the presence of con Normal LU in three patients and pathological in 38 patients (92.7%). Pathological CXR in 34 patients (82.8%) and pathological CT patológica in all patients submitted to examination(n=17). 14 areas (2 anterior, 2 lateral and 3 posterior), 10 seconds in each area, score from 0 to 3 points, where: 0= normal; 1 point= regular or irregular pleural line with visible and non-confluent vertical artifacts; 2 points= irregular pleural line with multiple and conludne vertical artifacts and/or subpleural consolidations; 3 points= extensive and dense white lung areas with or without larger consolidations. Portable, wireless device, with convex transducer. Lung global assessment is mandatory, since each pulmonary ar distinct stages of the disease. LU carried out at the emergency room in the first evaluation is ab global prognosis, the need for admission to the ICU and identify p death risk. Numerous and coalescent B lines with small multifocal consolidations in several regionsmost common. Pleural line thickening and irregularities. Increase in B lines in different degrees and extension. Small and multifocal consolidations limited to the subpleural space. Consolidations in mass with dynamic air bronchograms. CT with ground glass opacity (96.1%), followed by consolidations (75.8%) and crazy paving pattern (ground glass opacity with overlapping of inter and intralobular septal thickening) (60.9%). Most patients with bilateral and multifocal involvement. All patients showed peripheral pulmonary involvement. 8 areas (2 anterior and 2 lateral), in which the superior and inferior zones are delimited by the 3 rd ICS. Images analyzed and scored by three blinded medical doctors with 3 to 6 years of experience. Score (0-24): 0 = A lines with pleural sliding or up to 2 isolated B lines; 1 point = 3 or more spaced B lines restricted to a single ICS; 2 points= multiple B lines (>50% of the area evaluated), with NS CT is not suitable for the follow-up of critically ill patients (des standard) due to transportation and medical team infectio LU carried out every 48 hours after admission or when the examin necessary. Change in score ≥2 points meant improvement, while worsening and = 1, unchanged condition. The role of semi-quantitative scores in the follow-up of COV Unusual pleural effusion and rare pneumothorax. or without consolidations limited to the subpleural space; 3 points= confluent or tissue-like pattern B lines, characterized by dynamic air bronchograms, defined as pulmonary consolidations. Convex transducer and adjusted around 10 cm deep. pneumonia was studied. Positive LU correlation with CT to evaluate the LU accuracy was patients when compared to the severe ones. The patients had been the examination; therefore, the LU was used to evaluate the sever but not to diagnose the disease. The LU was more accurate in the worsening than the improvement or maintenance of the c LU used to verify alveolar recruitment after non-invasive CPAP. It was carried out before and after CPAP. CT is considered gold standard in the quantitative evaluation of recruitment and pulmonary aeration, but it is not carried out due to certain issues such as transport logistics, contamination, instability of critical patients, among others. 12 areas (anterior, lateral and posterior, divided into upper and lower sections), score from 0 to 3: 0= A lines or below 3 isolated B lines; 1= multiple and well-spaced B lines; 2= coalescent B lines with or without small subpleural consolidations; 3= pulmonary consolidation. Convex transducer. LU as a valid technique to assess alveolar recruitment, evaluation pulmonary water and improvement after CPAP application. Patie the PaO2/FiO2 relation after 1 hour of CPAP showed lower Pleural effusion in all patients, followed by diffuse and translobar subpleural consolidations, coalescent B lines and pleural line irregularities. No A line patterns were observed. After a 3-month follow-up, all patients were asymptomatic, presented normal echocardiogram, no effusion and persistence of pleural thickening. Cites CT as gold standard, but also the need for transfer of the critical/unstable patient, high infection risk and the ionizing radiation limits its use in children. 10 areas (4 anteriorbetween the sternal and anterior axillary lines; 2 lateralbetween the anterior and posterior axillary lines; 4 posteriorbetween the paravertebral and posterior axillary lines). Linear transducer. NS Cites sanitation/sterilization of transducers and the use of protection covers. Infection in children is unusual and less severe Case 1= increased B lines and focal pulmonary consolidation. Case 2= partially thickened pleural line, intensive B lines, consistent with pneumonia signs. Case 1= thorax X-ray indicating pulmonary infection. CT with irregular shadows of high density and bilateral ground glass opacity. Case 2= multiple nodes with bilateral inflammatory appearance. NS Using remote ultrasound robotic device assisted by the 5G technology. Real time robotic scan using big data, cloud storage and artificia robotic arm provided the examiners with protection and reduced professionals in contact with the patients. CT limitation in general application to all population groups (su women and children). Early detection of B lines, in patients with normal X-ray, corresponding to the ground glass opacities in the CT. CXR and CT at hospital admission, however, no findings were specified. 12 areas, BLUE (Bedside Lung Ultrasound in an Emergency) protocol, use of the Venice self-learning system with automatic identification of B lines (distinction from artifacts). Score: 0= ≤2 B lines; 1= 3 or 4 lines (B1 lines); 2 = ≥5 B lines (B2 lines); 3= consolidation. Microconvex transducer. Not specified, but exemplifies complete garments LU proved useful in the monitoring of the disease evo LU in the triage of SARS-CoV-2 infected patients to identify respiratory failure. Fragmented pleural thickening in 100 (83%) patients; irregular subpleural consolidations in at least one zone in 93 (78%) and pleural effusion in 9 (8%) CT with bilateral pulmonary infiltrates. CXR with bilateral infiltrates (39%); pleural effusion and rare lobar infiltrates (<15%). 12 areas (anterior, anterolateral and posterolateral), score from 0 to 36 points: 0= A lines; 1= B1 lines (separated= moderate loss of pulmonary aeration); 2= B2 lines (coalescent= severe loss of pulmonary aeration); 3= consolidation (=complete loss of aeration). The pleural thickening was determined qualitatively. Transducer used for cardiac evaluation. Complete LU identifies quickly the pulmonary involvement allowing str prediction of the need for mechanical ventilation, mortality a The main factor responsible for the LU worse score was a ne involvement of the anterior pulmonary segments, a finding tha clinically as an alert of imminent clinical deteriorati NS NS 12 areas with scores from 0 to 3 for each of them (0-36 in total). Score: 0 (normal aeration)= presence of pleural sliding with A lines or less than 2 vertical isolated B lines; 1 (moderate loss of pulmonary aeration)= spaced or coalescent B1 lines, multiple, well-defined or small juxtapleural consolidations; 2 ( severe loss of pulmonary aeration)= multiple vertical coalescent B2 lines or juxtapleural consolidations found int he whole area of one or two intercostal spaces and corresponding to alveolar edema; 3= pulmonary consolidations with static or dynamic air bronchograms up to the complete loss of aeration. Convex transducer (2-4 MHz). NS LU can be a more precise indicator of the ideal moment of intu oxygenation index and the respiratory rate. (23.5%). CXR in 28 patients: ground-glass opacity in 12 (42.9%); interstitial pattern in 13 (46.4%). Case 1= LU in 3-day old patient without consolidation or coalescent B pattern; during evolution, presence of coalescent B lines and consolidation in the lateral and posterior areas. Case 2= along the infection, more evident B pattern, mainly posterior with the appearance of consolidation. Blurred and thickened pleural line with normal pleural sliding. Case 3= most areas with A pattern and thin pleural line with normal pleural sliding and isolated B lines; in posterior regions, thickened and blurred pleural line with coalescent B lines and millimetric pleural consolidation; during the evolution, the findings disappeared. 12 evaluation areas. Considering regional alveolar-interstitial patterns such as multiple B lines (≥3) within the region evaluated using LU or the presence of ground glass opacities in the CT. Alveolar-interstitial Syndrome was defined as the presence of ≥2 regions with alveolar-interstitial pattern per side and bilateral positivity. LU and CT carried out in an interval ≤12 hours. LU was more sensitive than CT in the diagnosis of regional alve pattern, alveolar-interstitial syndrome, consolidation and pleu Irregular pleural line with partially confluent B lines, mainly anterior and above the left lung. Presence of pleural sliding. Consolidation with hepatic echogenic texture, air bronchogram and pleural effusion in the right costophrenic sinus. CT with ground glass opacities in the left apical lobe and consolidations in the right basal lobe. NS NS Patient developed SDRA and multiple organ failure and died on evolution. LU use only in case 4: pleural line thickening and irregularity. Diffuse B lines and consolidations. CXR in cases 1 and 2: unequal, diffuse alveolarinterstitial opacities, with peripheral predominance and pulmonary bases. CXR in case 4: no abnormalities found. CT in case 3: density diffusely increased with mainly ground glass peripheral bilateral distribution pattern, thickening of the interlobular sept or bronchiectasis. NS LU proposed as an alternative for the diagnosis and monitoring of higher sensitivity than CXR, despite its low specific Bilateral moderate B lines, without pleural effusion. CXR with interstitial thickening in the right mid and basal field. NS NS SARS-CoV-2 associated to increased risk of thromboembo inflammation, stasis and hypercoagulability conditi Patient with no signs of distal hypoperfusion at admission an examination confirming graft patency, the only possible explan hypercoagulability and COVID-19 related inflammation. P Bilateral involvement in 26 (100%) with predominance of basal, medial, or apical lobe involvement in 3 (12%). Pattern of alveolar-interstitial syndrome: (i) with distinct B lines in 7 (27%) patients; (ii) with confluent B lines (white lung) in 17 (73%) patients; (iii) subpleural consolidations in 17 (73%) patients; (iv) parenchymal consolidations in 13 (50%) patients. Lung ultrasound score 15±5. CT with, n (%): 26 (100) bilateral involvement, 21 (81) mixed axial distribution, 23 (88) involvement of 6 pulmonary lobes; 6 (23) predominance of basal, medial, or apical lobe involvement, 26 (100) Ground-glass opacities, 13 (50) subpleural lines, 15 (58) fat vessel sign, 4 (15) crazy paving sign, 2 (8) basal consolidations, 1 (4) centrolobular nodules, 1 (4) pleural effusion, 2 (8) lymphadenopathy. 8 areas, score from 0 to 3, scores 0-24 (points): 0= regular pleural line and presence of A lines; 1= fragmented pleural line, focal B lines; 2= irregular pleural line, subpleural consolidations; 3= white lung with or without consolidations. Convex transducer for panoramic view and linear for abnormalities in the pleural line. Exclusive transducers, machine and operator protection with IPE. 34% deaths of patients in hospital treatment. LU score, according to type, extension and severity of the altera statistically significant correlation with the CT severity score and air. LU was used in 48 (21.4%) patients and bilateral B lines were identified in 36 (76.6%) patients. CXR carried out in 80 (35.6%) patients. Findings consistent with normality in 19 (84%) patients. Scores and evaluation technique are not mentioned, portable device. NS In COVID-19 suspected patients, anosmia, high clinical probabilit bilateral B lines in LU increased the probability of disease id Irregular pleural line, B-lines, some coalescent, with bilateral patchy distribution, and small peripheral consolidations, which were larger in posterior-basal areas. Thoracic angioCT-scan ruled-out massive pulmonary thromboembolism but showed a pattern of ground glass and numerous consolidations of predominance in the A concerning association between COVID-19 and the novel inflammatory syndrome has been recently noticed and increas A severe cardiovascular involvement associated with pediatric C Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea One million cases of COVID-19: what have we learned Covid-19 in Brazil The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing, China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study High-resolution computed tomography manifestations of COVID-19 infections in patients of different ages Proposal for international standardization of the use of lung ultrasound for patients with COVID-19: a simple, quantitative, reproducible method Is there a role for lung ultrasound during the COVID-19 pandemic? COVID-19 outbreak: less stethoscope, more ultrasound Point-of-Care lung ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak How to perform lung ultrasound in pregnant women with suspected COVID-19 infection Can lung US help critical care clinicians in the early diagnosis of novel coronavirus (COVID-19) pneumonia? Just the facts: recommendations on point of care ultrasound use and machine infection control during the COVID-19 pandemic Serial bedside lung ultrasonography in a critically ill COVID-19 patient Lung ultrasound cannot be used to screen for Covid-19 in children The diagnosis of pneumonia in a pregnant woman with COVID-19 using maternal lung ultrasound COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review No dose" lung ultrasound correlation with "low dose" CT scan for early diagnosis of SARS-CoV-2 pneumonia Ultrasound findings in patients with COVID-19 pneumonia in early and late stages: two case-reports Lung ultrasound in the COVID-19 pandemic: a practical guide for obstetricians and gynecologists Lung ultrasound in the monitoring of COVID-19 infection A case of lung ultrasound findings in a 73-year-old male with COVID Contrast-enhanced ultrasound (CEUS) of the lung reveals multiple areas of microthrombi in a COVID-19 Lung ultrasound: a valuable tool for the assessment of dialysis patients with COVID-19 Lung ultrasonography in COVID-19: a gamechanger in the Stroke Unit? Modified lung ultrasound score for assessing and monitoring pulmonary aeration Point-of-care lung ultrasound in patients with COVID-19 -a narrative review Lung Ultrasound early detection and monitoring in Covid-19 pneumonia: fact and fiction Point-of-care ultrasound in COVID-19 pandemic International evidence-based recommendations for point-of-care lung ultrasound Ultrasound in COVID-19: a timeline of ultrasound findings in relation to CT Lung Ultrasound early detection and monitoring in Covid-19 Pneumonia: fact and fiction Clarifying the role of lung ultrasonography in COVID-19 respiratory disease Sonographic signs and patterns of COVID-19 pneumonia Challenges and opportunities for lung ultrasound in novel coronavirus disease (COVID-19) Use of lung ultrasound to differentiate Coronavirus Disease 2019 (COVID-19) pneumonia from community-acquired pneumonia prognostic value of lung ultrasonography in older nursing home residents affected by COVID-19 COVID-19 pneumonia Outcomes of universal SARS-CoV-2 Matern Fetal Neonatal Med Lung ultrasound score in evaluating the severity of Coronavirus Disease 2019 (COVID-19) Pneumonia Lung ultrasound score to monitor COVID-19 pneumonia progression in patients with ARDS Semiquantitative lung ultrasound scores in the evaluation and follow-up of critically ill patients with COVID-19: a single-center study Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 Short report -Usefulness of point-of-care ultrasound in pediatric SARS-CoV-2 infection Role of 5G-powered remote robotic ultrasound during the COVID-19 outbreak: insights from two cases Lung ultrasound for early diagnosis and severity assessment of pneumonia in patients with coronavirus disease 2019 Lung ultrasound predicts clinical course and outcomes in COVID-19 patients Lung ultrasound score in establishing the timing of intubation in COVID-19 interstitial pneumonia: A preliminary retrospective observational study Bedside wireless lung ultrasound for the evaluation of COVID-19 lung injury in senior nursing home residents Use of lung ultrasound in COVID-19: comparison with ultra-high-resolution Correlation between chest computed tomography and lung ultrasonography in patients with Coronavirus Disease 2019 (COVID-19) Point-of-care lung ultrasound in three neonates with COVID-19 The first case of COVID-19 in Bhutan Lung ultrasonography versus chest CT in COVID-19 pneumonia: a two-centered retrospective comparison study from China Lung ultrasound findings in COVID-19 pneumonia COVID-19 diagnosis through image Non-coalescent B lines in >3 zones coalescent B lines in >3 zones (32 patients); not consolidated hyperdense condition (30 patients) None 8 to 12 areas, score from 0 to 3, where: 0= normal pattern; A lines or insignificant B lines; 1= non-coalescent B lines in > 3 zones Multiple B lines and consolidations. White lung. CT: bilateral multiple lesions Bilateral, isolated or confluent B line pattern, pleural irregularity, presence of linear and subpleural consolidations CT in 51 patients: pleural thickening in 2 (1%); groundglass opacity in 37 (72.5%); septal thickening in 18 (35.2%) Coronavirus disease 2019; N= number of individuals; NS= not stated; IPE= individual protection equipment; HRCT= high resolution computed tomography; CT= computed tomography; LU= lung ultrasound; CXR= chest-X ray SDRA= acute respiratory distress syndrome; FiO2= fraction of inspired oxygen; CPAP= Continuous Positive Airway Pressure The authors are grateful to the professionals in the teams of the referenced pediatric urgency and emergency and pediatric pulmonology units as well as to the University of Campinas radiology department.Also, the authors thank Fernando Belluomini for collaboration in the data collection. This research did not receive any specific grant from funding agencies in the public, commercial, or not-forprofit sectors. years)all of them health care professionals.Veronese et al., 2020 (73) Divided into 4 groups: 1. light: light symptoms without TCAR alteration. 2. common: fever and signals of respiratory infection with pneumonia alterations in the TCAR. 3. severe: any of these symptoms, a) respiratory distress with FR ≥30, b) SpO2 ≤93% at rest or c) PaO2/FiO2 ≤300 mmHg. 4. critical: a) respiratory failure requiring mechanical ventilation, b) shock, c) admission in the ICU due to multiple organ failure. Case 1= cough Case 2= tightness in chest for a week, solved at admission. Without respiratory symptoms. Cho et al., 2020 (83)